The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of AREG exon 1 polymorphism with worse prognosis in Japanese and U.S. patients with gastric cancer.
Takeru Wakatsuki
No relevant relationships to disclose
Wu Zhang
No relevant relationships to disclose
Dongyun Yang
No relevant relationships to disclose
Mizutomo Azuma
No relevant relationships to disclose
Yan Ning
No relevant relationships to disclose
Nico Benjamin Volz
No relevant relationships to disclose
Sebastian Stintzing
No relevant relationships to disclose
Rita Elie El-Khoueiry
No relevant relationships to disclose
Joseph Ethan Li
No relevant relationships to disclose
Peter M. D. Wilson
No relevant relationships to disclose
Melissa Janae Labonte
No relevant relationships to disclose
Martin K. H. Maus
No relevant relationships to disclose
Yu Sunakawa
No relevant relationships to disclose
Wasaburo Koizumi
No relevant relationships to disclose
Masahiko Watanabe
No relevant relationships to disclose
Syma Iqbal
No relevant relationships to disclose
Afsaneh Barzi
No relevant relationships to disclose
Anthony B. El-Khoueiry
No relevant relationships to disclose
Manish A. Shah
No relevant relationships to disclose
Heinz-Josef Lenz
No relevant relationships to disclose